companydata.dkLEO PHARMA A/S: Financial statements 2014
CVR: 56759514
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 6,571,000,000 and a net result of DKK 1,544,000,000 compared with DKK 1,175,000,000 the year before. That is an increase of 13.6% compared with the year before. The profit margin was 23.5%. Equity amounted to DKK 24,523,000,000. The solvency ratio was 70.9%. The company had 4,712 employees in the financial year.
- Revenue
- 6,571,000,000 kr.
- Profit/Loss
- 1,544,000,000 kr.
- Equity
- 24,523,000,000 kr.
- Total Assets
- 34,609,000,000 kr.
- Employees
- 4,712
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
| 2013 | 5.8 mia. | - | 1.2 mia. | 23.1 mia. | 4733 |
Keep an eye on LEO PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 22, 2014, Lars Kjøller has joined the board of directors of LEO PHARMA A/S.
As of October 22, 2014, Marianne Viskum Olesen has left the board of directors of LEO PHARMA A/S.
As of June 30, 2014, Anders Bendsen Spohr has stepped down as director of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2013. Revenue came to DKK 5,782,000,000, and the net result was DKK 1,175,000,000.
As of March 27, 2014, Ingelise Saunders has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Morten Drewes Pedersen has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Allan Carsten Dahl has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Marianne Viskum Olesen has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, John Robert Weeks has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Per Håkon Schmidt has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.